Stryker (SYK) saw a positive improvement to its Relative Strength (RS) Rating on Monday, with an upgrade from 70 to 74.
↑ X NOW PLAYING How To Find Game-Changing StocksThis exclusive rating from Investor's Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
Over 100 years of market history shows that the stocks that go on to make the biggest gains often have an 80 or better RS Rating in the early stages of their moves. See if Stryker can continue to rebound and clear that threshold.
How To Invest In Stocks In Both Bull And Bear Markets
Stryker is building a flat base with a 398.20 entry. See if the stock can break out in volume at least 40% higher than normal.
Earnings grew 17% last quarter, up from 11% in the prior report. Revenue also increased, from 9% to 12%. Look for the next report on or around Jan. 28.
The company earns the No. 13 rank among its peers in the Medical-Products industry group. Globus Medical (GMED), Boston Scientific (BSX) and Insulet (PODD) are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。